Henderson, Nev.-based Spectrum Pharmaceuticals Inc. added William Ashton to its board of directors.
Ashton was previously vice president for U.S. sales at Amgen Inc. His appointment expands the company's board to nine members.
Spectrum develops drug products for blood diseases and cancer.
